AZN
Price
$69.57
Change
+$0.02 (+0.03%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
208.98B
2 days until earnings call
LLY
Price
$884.57
Change
+$24.84 (+2.89%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
739.66B
4 days until earnings call
Ad is loading...

AZN vs LLY

Header iconAZN vs LLY Comparison
Open Charts AZN vs LLYBanner chart's image
AstraZeneca
Price$69.57
Change+$0.02 (+0.03%)
Volume$53.03K
Capitalization208.98B
Eli Lilly & Co
Price$884.57
Change+$24.84 (+2.89%)
Volume$20.23K
Capitalization739.66B
AZN vs LLY Comparison Chart
Loading...
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZN vs. LLY commentary
Apr 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZN is a Buy and LLY is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 27, 2025
Stock price -- (AZN: $69.55 vs. LLY: $859.73)
Brand notoriety: AZN and LLY are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AZN: 55% vs. LLY: 78%
Market capitalization -- AZN: $208.98B vs. LLY: $739.66B
AZN [@Pharmaceuticals: Major] is valued at $208.98B. LLY’s [@Pharmaceuticals: Major] market capitalization is $739.66B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZN’s FA Score shows that 2 FA rating(s) are green whileLLY’s FA Score has 2 green FA rating(s).

  • AZN’s FA Score: 2 green, 3 red.
  • LLY’s FA Score: 2 green, 3 red.
According to our system of comparison, both AZN and LLY are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZN’s TA Score shows that 4 TA indicator(s) are bullish while LLY’s TA Score has 5 bullish TA indicator(s).

  • AZN’s TA Score: 4 bullish, 5 bearish.
  • LLY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LLY is a better buy in the short-term than AZN.

Price Growth

AZN (@Pharmaceuticals: Major) experienced а +2.90% price change this week, while LLY (@Pharmaceuticals: Major) price change was +2.35% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.23%. For the same industry, the average monthly price growth was -2.27%, and the average quarterly price growth was -8.41%.

Reported Earning Dates

AZN is expected to report earnings on Jul 24, 2025.

LLY is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.23% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LLY($740B) has a higher market cap than AZN($209B). LLY has higher P/E ratio than AZN: LLY (131.13) vs AZN (35.30). LLY YTD gains are higher at: 11.556 vs. AZN (7.667). AZN has higher annual earnings (EBITDA): 13.4B vs. LLY (8.57B). AZN has more cash in the bank: 5.86B vs. LLY (2.93B). LLY has less debt than AZN: LLY (25.2B) vs AZN (28.6B). AZN has higher revenues than LLY: AZN (45.8B) vs LLY (34.1B).
AZNLLYAZN / LLY
Capitalization209B740B28%
EBITDA13.4B8.57B156%
Gain YTD7.66711.55666%
P/E Ratio35.30131.1327%
Revenue45.8B34.1B134%
Total Cash5.86B2.93B200%
Total Debt28.6B25.2B113%
FUNDAMENTALS RATINGS
AZN vs LLY: Fundamental Ratings
AZN
LLY
OUTLOOK RATING
1..100
5818
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
89
Overvalued
PROFIT vs RISK RATING
1..100
296
SMR RATING
1..100
5014
PRICE GROWTH RATING
1..100
7248
P/E GROWTH RATING
1..100
6791
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZN's Valuation (25) in the Pharmaceuticals Major industry is somewhat better than the same rating for LLY (89). This means that AZN’s stock grew somewhat faster than LLY’s over the last 12 months.

LLY's Profit vs Risk Rating (6) in the Pharmaceuticals Major industry is in the same range as AZN (29). This means that LLY’s stock grew similarly to AZN’s over the last 12 months.

LLY's SMR Rating (14) in the Pharmaceuticals Major industry is somewhat better than the same rating for AZN (50). This means that LLY’s stock grew somewhat faster than AZN’s over the last 12 months.

LLY's Price Growth Rating (48) in the Pharmaceuticals Major industry is in the same range as AZN (72). This means that LLY’s stock grew similarly to AZN’s over the last 12 months.

AZN's P/E Growth Rating (67) in the Pharmaceuticals Major industry is in the same range as LLY (91). This means that AZN’s stock grew similarly to LLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZNLLY
RSI
ODDS (%)
Bullish Trend 6 days ago
44%
Bullish Trend 6 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
51%
Bearish Trend 6 days ago
50%
Momentum
ODDS (%)
Bullish Trend 6 days ago
53%
Bullish Trend 6 days ago
68%
MACD
ODDS (%)
N/A
Bullish Trend 6 days ago
66%
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
45%
Bullish Trend 6 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
43%
Bearish Trend 6 days ago
53%
Advances
ODDS (%)
Bullish Trend 14 days ago
55%
Bullish Trend 14 days ago
69%
Declines
ODDS (%)
Bearish Trend 12 days ago
43%
Bearish Trend 21 days ago
53%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
59%
Bullish Trend 6 days ago
64%
Aroon
ODDS (%)
Bearish Trend 6 days ago
41%
Bearish Trend 6 days ago
54%
View a ticker or compare two or three
Ad is loading...
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA259.518.77
+3.50%
Tesla
SPY546.6911.27
+2.10%
SPDR® S&P 500® ETF
AAPL208.373.77
+1.84%
Apple
BTC.X93943.800000244.687500
+0.26%
Bitcoin cryptocurrency
GME27.08-0.04
-0.15%
GameStop Corp

AZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZN has been loosely correlated with NVS. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AZN jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZN
1D Price
Change %
AZN100%
+1.52%
NVS - AZN
57%
Loosely correlated
+0.94%
GSK - AZN
49%
Loosely correlated
+1.27%
LLY - AZN
37%
Loosely correlated
+3.65%
SNY - AZN
36%
Loosely correlated
+0.98%
OGN - AZN
35%
Loosely correlated
+5.48%
More

LLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with AZN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
+3.65%
AZN - LLY
37%
Loosely correlated
+1.52%
BIIB - LLY
32%
Poorly correlated
+1.13%
OGN - LLY
25%
Poorly correlated
+5.48%
NVS - LLY
25%
Poorly correlated
+0.94%
MRK - LLY
23%
Poorly correlated
+1.40%
More